Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × Radionuclide Imaging × 1 year × Clear all

Sponsor

Conditions

Lung Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Nose Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Colonic Neoplasms 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Anus Neoplasms 1

Interventions

Pluvicto 5 olaparib 3 Prednisone 3 Abiraterone Acetate 3 testosterone 17 beta-cypionate 2 radium Ra 223 dichloride 2 enzalutamide 2 darolutamide 2 Prednisolone 2 Docetaxel 2 sipuleucel-T 1 sarilumab 1 rucaparib 1 niraparib 1 lactitol 1 fludarabine phosphate 1 fludarabine 1 fluciclovine F-18 1 enfortumab vedotin 1 ebastine 1 copanlisib 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 Standard of Care 1 Radium-223 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡